Brain Tumor Pathology

Papers
(The median citation count of Brain Tumor Pathology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
H3 G34-mutant high-grade glioma32
Glioblastomas harboring gene fusions detected by next-generation sequencing27
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles24
Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 cases24
The molecular framework of pediatric-type diffuse gliomas: shifting toward the revision of the WHO classification of tumors of the central nervous system19
Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L117
EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations17
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis15
Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas14
Primary spinal intramedullary Ewing-like sarcoma harboring CIC-DUX4 translocation: a similar cytological appearance as its soft tissue counterpart but no lobulation in association with desmoplastic st13
Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features12
Molecular subtyping of ependymoma and prognostic impact of Ki-6712
Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature11
The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas11
Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report10
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma10
Implications of immune cells in oncolytic herpes simplex virotherapy for glioma9
Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature8
Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report8
Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma8
Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy8
Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options8
Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors8
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features8
Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development7
Prognostic significance of TERT promoter mutations in adult-type diffuse gliomas7
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas7
Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?7
Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR7
Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas6
Liquid biomarkers in glioma6
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused6
Diffusely infiltrating glioma with CREBBP–BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report6
T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings5
Clinical implications of molecular analysis in diffuse glioma stratification5
Update of the 2021 WHO classification of tumors of the central nervous system: adult diffuse gliomas5
Masked malignant phenotype with a benign appearance: beat-up copy number profile may be the key for hemangioblastoma dissemination5
Genetic characterization of an aggressive optic nerve pilocytic glioma5
A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature5
Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion5
Aggressive nonfunctioning pituitary neuroendocrine tumors5
Ribosomal proteins induce stem cell-like characteristics in glioma cells as an “extra-ribosomal function”5
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis4
Emerging glioneuronal and neuronal tumors: case-based review4
Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation4
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis4
Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms4
Metabolic, immunohistochemical, and genetic profiling of a cerebellar liponeurocytoma with spinal dissemination: a case report and review of the literature4
Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes4
Frequency of mismatch repair protein deficiency and PD-L1 in high-grade gliomas in adolescents and young adults (AYA)4
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity3
A dedifferentiated intracranial solitary fibrous tumor with osteosarcoma components: rapid tumor progression and lethal clinical course3
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement3
Timing of H3K27me3 loss in secondary anaplastic meningiomas3
Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence3
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report3
Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma3
Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors3
Loss of H3K27me3 in WHO grade 3 meningioma3
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma3
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma3
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the T3
Primary central nervous system lymphomas associated with chronic inflammation: diagnostic pitfalls of central nervous system lymphomas3
0.020088195800781